期刊文献+

子痫前期孕妇血清和胎盘组织中干扰素-γ诱导蛋白10的表达及意义 被引量:2

Expression and significance of IFN-γ inducible protein 10 in serum and placenta with preeclampsia pregnancy
暂未订购
导出
摘要 目的:检测子痫前期孕妇胎盘组织及血清中干扰素-γ诱导蛋白10(IP-10)的表达情况,探讨其与子痫前期发病的关系。方法:收集正常妊娠、轻度子痫前期、重度子痫前期孕妇的胎盘组织及血清,采用ELISA、实时荧光定量PCR及Western blot方法检测IP-10在3组孕妇胎盘组织及血清中的表达变化。结果:ELISA结果显示,与正常对照组相比,轻度子痫前期组、重度子痫前期组孕妇血清中IP-10表达均明显增加(P均<0.05);实时荧光定量PCR及Western blot结果显示,与正常对照组相比,轻度子痫前期组、重度子痫前期组孕妇胎盘组织中IP-10 mRNA及蛋白表达水平均有不同程度增高(P均<0.05)。结论:子痫前期孕妇胎盘及血清中IP-10表达升高,可能与子痫前期的发病有关。 Objective:To detect interferon-gamma inducible protein 10(IP-10) in the placenta and serum of gravidas with preeclampsia in order to evaluate the relationship of IP-10 with preeclampsia.Methods:We collected placenta and serum from normal gravidas,gravidas with mild preeclampsia and gravidas with severe preeclampsia.The expression of IP-10 in the placenta and serum was detected by ELISA,real-time PCR and Western blot.Results:As the results of ELISA,the IP-10 expression levels in serum of patients with severe or mild preeclampsia were significantly higher than those in normal pregnancy group(P0.05).And as the results of real-time PCR and Western blot,the expression levels of IP-10 in the placenta with severe or mild preeclampsia were all significantly higher than those in normal pregnancy group(P0.05).Conclusion:The elevated IP-10 expression in the placenta and serum may play an important role in preeclampsia.
出处 《现代妇产科进展》 CSCD 2012年第9期669-672,共4页 Progress in Obstetrics and Gynecology
基金 南通市社会发展计划(No:S2008032) 江苏省卫生厅"科教兴卫工程"苏州大学附属第一医院临床免疫实验室开放课题(No:KF200973)
关键词 干扰素-γ诱导蛋白10 子痫前期 血清 胎盘 干扰素诱导剂 干扰素-Γ IFN-γ inducible protein 10 Pre-eclampsia Serum Placenta Interferon inducers Interferon-gamma
  • 相关文献

参考文献16

二级参考文献78

  • 1王佳慧,王守安,于翔辉,马青.大鼠妊高征模型的建立初探[J].黑龙江医药科学,2004,27(4):52-53. 被引量:4
  • 2胡文胜,王正平,董岳,王焓知.子痫前期患者血清和胎盘的Fas与FasL的变化及意义[J].浙江大学学报(医学版),2005,34(6):499-502. 被引量:8
  • 3Guo J, Wang B, Zhang M, et al. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther, 2002 ; 9 (12) : 793-803.
  • 4Angiolillo AL, Sgadari C, Taub DD, etal. Human interferoninducible protein 10 is a potent inhibitor of angiogenesis in vivo. J ExpMed,1995,182 (1):155-162.
  • 5Phillips AJ. The challenge of gene therapy and DNA delivery. J Pharm Pharmacol,2001 ; 53(9) : 1169-1174.
  • 6Pulaski BA, Terman DS, Khan S, et al. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histoeompatibility complex class II , and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Caneer Res,2000,60(10) :2710-2715.
  • 7Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res, 1998 , 58 (7) 1486-1493.
  • 8Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol,1994,6(6):865-873.
  • 9Kim CH, Broxmeyer HE. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol,1999 ,65(1):6-15.
  • 10Keyser J, Sehultz J, Ladell K, et al. IP-10-eneoding plasmid DNA therapy exhibits anti-tumor and anti-metastatie effieiency. Exp Dermatol,2004,13(6) ;380-390.

共引文献75

同被引文献19

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部